driven by the PitchBook Platform
Developer of molecular-level cell-based treatments. The company develops immunology based treatments and drugs for the treatment of cancer and auto-immune diseases.
You’re viewing a free company profile from the PitchBook Platform. To explore NantCell’s full profile, request a free trial.
© 2017 PitchBook Data. All rights reserved. PitchBook is a financial technology company that provides data on the capital markets.